Cet anticorps anti-ELOVL7 Polyclonal Lapin (ABIN499788) détecte spécifiquement ELOVL7 dans WB, IHC (p) et EIA.
L’anticorps est réactif avec des échantillons de Humain et Souris.
ELOVL7
Reactivité: Humain, Souris
WB, ELISA
Hôte: Lapin
Polyclonal
APC
Indications d'application
ELISA. Western blot: 1 - 2 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
1.0 mg/mL
Buffer
PBS containing 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freezing and thawing.
Stock
-20 °C
Stockage commentaire
Store the antibody (in aliquots) at -20 °C.
Antigène
ELOVL7
(ELOVL Fatty Acid Elongase 7 (ELOVL7))
Autre désignation
ELOVL7
Sujet
Lipogenesis is a key event in the energy storage system and is controlled by the transcription factor sterol regulatory element-binding protein (SREBP)-1. Elongation of very long chain fatty acids protein 7 (ELOVL7) is a member of fatty acyl-CoA elongase gene family that elongates saturated very-long-chain fatty acids (SVLFA, C20:0-) and has been suggested to be involved in prostate cancer growth through saturated long-chain fatty acid metabolism. The metabolic pathways of long-chain fatty acids play an important role in the maintenance of membrane lipid composition and the generation of cell signaling precursor molecules such as eicosanoids and sphingosine-1 phosphate. Overexpression of ELOVL7 results in lipid accumulation in differentiated adipocytes, its expression is regulated by the microRNA miR-219.Synonyms: 3-keto acyl-CoA synthase ELOVL7, Elongation of very long chain fatty acids protein 7